Fund profile · Compiled from public sources

MPM BioImpact

Boston, Massachusetts, United States · Seed → Growth

Their stated focus (public profile)

MPM BioImpact is a biotechnology investment firm with over 30 years of experience investing in private and public companies across all stages of drug development, from seed to public markets. The firm focuses on building and backing innovative companies seeking to deliver transformative therapies to patients, with a particular emphasis on impact investing aligned with the Global Standards for impact management. It manages over $3 billion AUM across early-stage venture funds, private/public impact funds, and a public equities fund.

Stages: Seed → Growth

Sectors: Life sciences, Radiopharmaceuticals, Healthtech

On file: 7 companies on record

Website: mpmbioimpact.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →